Fundraising FoxAbintus Bio
San Diego, US · Founded 2020 · Delaware corporation · 2 known investors
Find your way into Abintus Bio
Sign up to see every warm intro you have to Abintus Bio
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Abintus Bio team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
Abintus Bio was founded in 2020 by Douglas J. Jolly.
DJ
Douglas J. JollyFounderDouglas J. Jolly is a founder of Abintus Bio with three decades of experience in gene therapy development and manufacturing. He has held senior executive roles at Viagene, Chiron, Oxford BioMedica, Advantagene, and Tocgen, and has authored over 125 scientific publications and holds more than 50 patents.
CE
Carlos E. IbanezNamed on SEC filing
RA
Robert Anthony WilliamsonNamed on SEC filing
TW
Troy WilsonNamed on SEC filing
MM
Michael MartinNamed on SEC filing
NA
Nicholas A. Boyle, Ph.D.Named on SEC filing
Investors · 2
Takeda VenturesreportedCambridge · $1M – $5M
How we know: funding news · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$13.7M disclosed across 1 round · 2022
▶$13.7MraisedAug 2022 · 37 investors · BiotechnologyRule 506(b)
▶$13.7MraisedAug 2022 · 37 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Carlos E. IbanezExecutive Officer
- Robert Anthony WilliamsonDirector
- Troy WilsonDirector
- Michael MartinDirector
- Nicholas A. Boyle, Ph.D.Executive Officer, Director
- Offering amount
- $15.7M
- Amount sold
- $13.7M
- First sale
- Aug 2022
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- Who founded Abintus Bio?
- Abintus Bio was founded by Douglas J. Jolly in 2020.
- Who are Abintus Bio's investors?
- Abintus Bio's investors include BioBrit, Takeda Ventures.
- How much funding has Abintus Bio raised?
- Abintus Bio has disclosed $13.7M raised across 1 round.
- Where is Abintus Bio headquartered?
- Abintus Bio is headquartered in San Diego, US.